Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03891979
Title Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma
Recruitment Withdrawn
Gender both
Phase FDA approved
Variant Requirements No
Sponsors New York University School of Medicine
Indications
Therapies
Age Groups: senior | adult | child
Covered Countries USA

Facility Status City State Zip Country Details
NYU Langone Health New York New York 10016 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field